Stock SHC SOTERA HEALTH COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sotera Health Company

Equities

SHC

US83601L1026

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
11.18 USD +0.81% Intraday chart for Sotera Health Company -0.18% -33.65%
May. 31 Sotera Health Unit Closes $2.26 Billion of Financing MT
May. 21 Piper Sandler Initiates Sotera Health at Neutral Rating With $13 Price Target MT

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,802 6,663 2,350 4,762 3,165 - -
Enterprise Value (EV) 1 9,560 8,341 3,976 6,767 5,064 4,917 3,165
P/E ratio -172 x 57.4 x -10 x 93.6 x 34.3 x 23.2 x 18.6 x
Yield - - - - - - -
Capitalization / Revenue 9.54 x 7.15 x 2.34 x 4.54 x 2.87 x 2.69 x 2.51 x
EV / Revenue 11.7 x 8.95 x 3.96 x 6.45 x 4.59 x 4.18 x 2.51 x
EV / EBITDA 22.8 x 17.3 x 7.85 x 12.8 x 9.17 x 8.23 x 4.87 x
EV / FCF 143 x 46.5 x 41.6 x -18.7 x 24.5 x 17.7 x 10.5 x
FCF Yield 0.7% 2.15% 2.4% -5.36% 4.09% 5.65% 9.52%
Price to Book 14.4 x 11.4 x 6.72 x 10.7 x 5.76 x 4.58 x -
Nbr of stocks (in thousands) 284,321 282,917 282,113 282,623 283,071 - -
Reference price 2 27.44 23.55 8.330 16.85 11.18 11.18 11.18
Announcement Date 3/9/21 3/1/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 778.3 818.2 931.5 1,004 1,049 1,102 1,177 1,263
EBITDA 1 - 419.9 481.2 506.2 528 552 597.4 649.7
EBIT 1 - 356.6 417.1 442.2 451.5 476.2 519 562.6
Operating Margin - 43.58% 44.77% 44.06% 43.02% 43.2% 44.09% 44.54%
Earnings before Tax (EBT) 1 - -38.86 175.7 - - 132.2 165.6 213.6
Net income 1 -20.85 -38.62 116.9 -233.6 51.38 92.47 136.9 172.6
Net margin -2.68% -4.72% 12.55% -23.27% 4.9% 8.39% 11.63% 13.67%
EPS 2 - -0.1600 0.4100 -0.8300 0.1800 0.3263 0.4811 0.6000
Free Cash Flow 1 - 67.08 179.4 95.58 -362.7 207 277.8 301.3
FCF margin - 8.2% 19.26% 9.52% -34.57% 18.78% 23.6% 23.86%
FCF Conversion (EBITDA) - 15.98% 37.28% 18.88% - 37.5% 46.51% 46.37%
FCF Conversion (Net income) - - 153.47% - - 223.85% 202.9% 174.56%
Dividend per Share 2 - - - - - - - -
Announcement Date 9/2/20 3/9/21 3/1/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 241.2 236.8 266.6 248.7 251.6 220.6 255.3 263.2 310.2 248.2 266.4 283.6 304.3 262.3 284.3
EBITDA 1 124.7 115.3 136.1 125.2 129.6 98.47 128.5 134.3 166.7 111.9 132.3 146.4 161.2 121.5 143.1
EBIT 1 108 99.48 120.4 109.3 113.1 79.54 109.5 116.3 146.1 91.64 114.2 127.9 143 101.3 123
Operating Margin 44.76% 42.02% 45.15% 43.93% 44.96% 36.06% 42.89% 44.2% 47.09% 36.92% 42.87% 45.09% 46.98% 38.6% 43.27%
Earnings before Tax (EBT) 1 - - - - - - - - - - 26.15 40.06 54.95 16.35 34.08
Net income 1 36 30.64 30.42 25.09 -319.7 2.842 23.51 -13.66 38.68 6.323 22.17 30.51 40.94 14.52 28.5
Net margin 14.92% 12.94% 11.41% 10.09% -127.08% 1.29% 9.21% -5.19% 12.47% 2.55% 8.32% 10.76% 13.45% 5.53% 10.03%
EPS 2 0.1300 0.1100 0.1100 0.0900 -1.140 0.0100 0.0800 -0.0500 0.1400 0.0200 0.0679 0.0981 0.1347 0.0500 0.1000
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 3/1/22 5/5/22 8/4/22 11/2/22 2/28/23 5/3/23 8/3/23 11/1/23 2/27/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 1,758 1,679 1,626 2,005 1,899 1,752 -
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - 4.188 x 3.488 x 3.212 x 3.796 x 3.44 x 2.933 x -
Free Cash Flow 1 - 67.1 179 95.6 -363 207 278 301
ROE (net income / shareholders' equity) - - 47.3% 57.7% 58% 41.2% 37.9% 36.3%
ROA (Net income/ Total Assets) - 3.71% 8.86% 9.15% 7.37% 8.3% 9.2% -
Assets 1 - -1,041 1,320 -2,553 697.1 1,114 1,489 -
Book Value Per Share 2 - 1.900 2.070 1.240 1.570 1.940 2.440 -
Cash Flow per Share - 0.5100 0.3700 - - - - -
Capex 1 - 53.5 102 182 215 216 178 180
Capex / Sales - 6.54% 10.97% 18.17% 20.49% 19.59% 15.09% 14.25%
Announcement Date 9/2/20 3/9/21 3/1/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Sotera Health Company

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
11.18 USD
Average target price
14.71 USD
Spread / Average Target
+31.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
SOTERA HEALTH COMPANY Stock Sotera Health Company
-33.65% 3.14B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.52% 87.77B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-24.52% 70.35B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-5.56% 25.03B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.31% 17.73B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-14.25% 16.31B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.97% 15.48B
NATERA, INC. Stock Natera, Inc.
+70.11% 13.52B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.20% 13.01B
DAVITA INC. Stock DaVita Inc.
+40.44% 12.9B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. SHC Stock
  4. Financials Sotera Health Company